Clinical Trial Update: Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating conversion to lamotrigine extended-release monotherapy for partial epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy Partial

Drugs mentioned

• Lamictal Extended-Release (lamotrigine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy, Partial | Phase 3 | Status: COMPLETED | Results posted: 2009-11-25